Home » Topics » BioWorld Science

BioWorld Science
RSS

VC-2 vaccine confers protection against viral ocular immunopathogenesis through T-cell infiltration

Jan. 3, 2022

Inhaled remdesivir shows efficacy in nonhuman primate model of SARS-CoV-2 infection

Jan. 3, 2022

Siglec-15 promotes osteosarcoma tumor progression

Jan. 3, 2022

Novel halogenated phenoxychalcones described with activity in breast cancer cell lines

Jan. 3, 2022

Mission Therapeutics synthesizes USP30 inhibitors

Jan. 3, 2022

Roche presents compounds for Gram-negative bacterial infections

Jan. 3, 2022

Betta Pharmaceuticals divulges new PTPN11 inhibitors

Jan. 3, 2022

Chinese researchers disclose SOS1 inhibitors

Jan. 3, 2022

Medshine Discovery patents new GLP-1 receptor agonists

Jan. 3, 2022

Discovery of novel BU-4664L derivatives with potential anticancer activity

Jan. 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...